Sfoglia per Autore  

Opzioni
Mostrati risultati da 21 a 40 di 56
Titolo Data di pubblicazione Autore(i) File
Targeting the tumor and its microenvironment by a dual-function decoy Met receptor 2004 MICHIELI P; MAZZONE M; BASILICO C; CAVASSA S; SOTTILE A; NALDINI L; P. COMOGLIO
An uncleavable form of pro-scatter factor suppresses tumor growth and dissemination in mice 2004 MAZZONE M; BASILICO C; CAVASSA S; PENNACCHIETTI S; RISIO M; NALDINI L; PM COMOGLIO; MICHIELI P
HGF-MSP chimera protects kidneys from ischemia-reperfusion injury. 2007 Xue F; Isaka Y; Takahara T; Imamura R; Suzuki C; Ichimaru N; Michieli P; Takahara S.
A high affinity hepatocyte growth factor-binding site in the immunoglobulin-like region of Met 2008 Basilico C; Arnesano A; Galluzzo M; Comoglio PM; Michieli P
Magic-factor 1, a partial agonist of Met, induces muscle hypertrophy by protecting myogenic progenitors from apoptosis 2008 Cassano M; Biressi S; Finan A; Benedetti L; Omes C; Boratto R; Martin F; Allegretti M; Broccoli V; Cusella De Angelis G; Comoglio PM; Basilico C; Torrente Y; Michieli P; Cossu G; Sampaolesi M
Metron factor-1 prevents liver injury without promoting tumor growth and metastasis 2008 Takahara T; Xue F; Mazzone M; Yata Y; Nonome K; Kanayama M; Kawai K; Pisacane AM; Takahara S; Li XK; Comoglio PM; Sugiyama T; Michieli P
HIGH AFFINITY BINDING SITE OF HGFR AND METHODS FOR IDENTIFICATION OF ANTAGONISTS THEREOF 2009 CRISTINA BASILICO; PAOLO MICHIELI; PAOLO CARMINATI; PAOLO MARIA COMOGLIO
Expression and Functional Regulation of Myoglobin in Epithelial Cancers 2009 Flonta SE; Arena S; Pisacane A; Michieli P; Bardelli A
Prevention of hypoxia by myoglobin expression in human tumor cells promotes differentiation and inhibits metastasis 2009 Galluzzo M; Pennacchietti S; Rosano S; Comoglio PM; Michieli P
Hypoxia, angiogenesis and cancer therapy: to breathe or not to breathe? 2009 Michieli P
Monovalency unleashes the full therapeutic potential of the DN-30 anti-Met antibody 2010 G. Pacchiana;C. Chiriaco;M. C. Stella;F. Petronzelli;R. D. Santis;M. Galluzzo;P. Carminati;P. M. Comoglio;P. Michieli;E. Vigna
Targeted anticancer therapy by a recombinant monovalent antibody against the MET oncogene 2011 P. Comoglio; E. Vigna; P. Michieli
MAGIC-FACTOR, A PARTIAL AGONIST OF MET, ACTS AS A SAFE HEPATOTROPHIC CYTOKINE 2011 T. Takahara; K. Kawai; T. Sugiyama; M. Asahi; P. Michieli
Targeted therapies: Tivantinib-a cytotoxic drug in MET inhibitor's clothes? 2013 Michieli P; Di Nicolantonio F
Tivantinib (ARQ197) Displays Cytotoxic Activity That Is Independent of Its Ability to Bind MET 2013 C. Basilico;S. Pennacchietti;E. Vigna;C. Chiriaco;S. Arena;A. Bardelli;D. Valdembri;G. Serini;P. Michieli
Tivantinib (ARQ197) displays cytotoxic activity that is independent of its ability to bind MET--response. 2013 Michieli P;Basilico C;Pennacchietti S
New antibody fragments, compositions and uses thereof 2014 Elisa Vigna; Paolo Michieli; Paolo Maria Comoglio
Targeted therapy by gene transfer of a monovalent antibody fragment against the Met oncogenic receptor. 2014 Vigna E;Pacchiana G;Chiriaco C;Cignetto S;Fontani L;Michieli P;Comoglio PM
ADAM17-dependent c-MET-STAT3 signaling mediates resistance to MEK inhibitors in KRAS mutant colorectal cancer. 2014 Van Schaeybroeck S;Kalimutho M;Dunne PD;Carson R;Allen W;Jithesh PV;Redmond KL;Sasazuki T;Shirasawa S;Blayney J;Michieli P;Fenning C;Lenz HJ;Lawler M;Longley DB;Johnston PG
Microenvironment-derived HGF overcomes genetically determined sensitivity to anti-MET drugs. 2014 Pennacchietti S;Cazzanti M;Bertotti A;Rideout WM ;Han M;Gyuris J;Perera T;Comoglio PM;Trusolino L;Michieli P
Mostrati risultati da 21 a 40 di 56
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile